Search Results - "Okajima, Eijiro"

Bacillus Calmette-Guérin-unresponsive non-muscle invasive bladder cancer outcomes in patients without radical cystectomy by Iida, Kota, Miyake, Makito, Murakami, Kaoru, Komiyama, Motokiyo, Okajima, Eijiro, Sazuka, Tomokazu, Nishiyama, Naotaka, Yasumoto, Hiroaki, Kimura, Takahiro, Ito, Akihiro, Shiga, Kenichiro, Yamagishi, Atsushi, Kikuchi, Hiroshi, Sugimoto, Mikio, Taoka, Rikiya, Kobayashi, Takashi, Kojima, Takahiro, Kitamura, Hiroshi, Nishiyama, Hiroyuki, Fujimoto, Kiyohide

“…Background Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) is a newly defined subtype that is unlikely to benefit from…”
Get full text

Dissociated response among multiple metastatic lesions in the patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors by Negishi, Takahito, Nakagawa, Tohru, Nishiyama, Naotaka, Kitamura, Hiroshi, Okajima, Eijiro, Furubayashi, Nobuki, Hori, Yoshifumi, Kuroiwa, Kentarou, Son, Yuhyon, Seki, Narihito, Tomoda, Toshihisa, Nakamura, Motonobu

“…Abstract Introduction Metastases from renal cell carcinoma develop in various organs. However, the breadth of discrepancy in response to immune checkpoint…”
Get full text

Docetaxel‐based chemotherapy combined with dexamethasone 1 mg daily oral administration for castration‐resistant prostate cancer: Long‐term outcomes by Tanaka, Nobumichi, Nishimura, Kazuo, Okajima, Eijiro, Ina, Kenji, Ogawa, Osamu, Nagata, Hirohiko, Akakura, Koichiro, Fujimoto, Kiyohide, Gotoh, Momokazu, Teramukai, Satoshi, Hirao, Yoshihiko

“…Objectives To report long‐term outcome survival analysis of docetaxel‐based chemotherapy combined with dexamethasone in castration‐resistant prostate cancer…”
Get full text

A Multicenter, Single-Arm, Prospective Trial to Evaluate Efficacy and Safety of Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Carboplatin (DD-MVACarbo) Chemotherapy for Cisplatin-Ineligible Patients with Advanced Urothelial Cancer: Study Protocol of the CARBUNCLE Trial by Miyake, Makito, Anai, Satoshi, Iemura, Yusuke, Ichikawa, Kazuki, Miyamoto, Tatsuki, Tomioka, Atsushi, Kuwada, Masaomi, Itami, Yoshitaka, Hosokawa, Yukinari, Matsumura, Yoshiaki, Okajima, Eijiro, Torimoto, Kazumasa, Nishimura, Nobutaka, Tomizawa, Mitsuru, Shimizu, Takuto, Hori, Shunta, Morizawa, Yosuke, Gotoh, Daisuke, Nakai, Yasushi, Fujimoto, Kiyohide

“…Unresectable, metastatic, advanced urothelial carcinoma (aUC) is an aggressive disease and is treated with platinum-containing first-line chemotherapy,…”
Get full text

Integrative assessment of clinicopathological parameters and the expression of PD‑L1, PD‑L2 and PD‑1 in tumor cells of retroperitoneal sarcoma by Miyake, Makito, Oda, Yuki, Nishimura, Nobutaka, Morizawa, Yosuke, Ohnishi, Sayuri, Hatakeyama, Kinta, Fujii, Tomomi, Hori, Shunta, Gotoh, Daisuke, Nakai, Yasushi, Anai, Satoshi, Torimoto, Kazumasa, Tsukamoto, Shinji, Fujii, Hiromasa, Kido, Akira, Honoki, Kanya, Matsumura, Yoshiaki, Okajima, Eijiro, Tanaka, Nobumichi, Fujimoto, Kiyohide

“…Evidence is limited regarding the immunologic profile and immune microenvironment of soft tissue sarcoma subtypes. The aim of the present study was to describe…”
Get full text

The efficacy and safety of docetaxel-based chemotherapy combined with dexamethasone 1 mg daily oral administration: JMTO Pca 10-01 phase II trial by Tanaka, Nobumichi, Nishimura, Kazuo, Okajima, Eijiro, Ina, Kenji, Ogawa, Osamu, Nagata, Hirohiko, Akakura, Koichiro, Fujimoto, Kiyohide, Gotoh, Momokazu, Teramukai, Satoshi, Hirao, Yoshihiko

“…Previously, one randomized control trial (TAX327) revealed the efficacy of docetaxel-based chemotherapy combined with prednisone. On the other hand, several…”
Get full text

Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association by Kikuchi, Eiji, Fujimoto, Hiroyuki, Mizutani, Yoichi, Okajima, Eijiro, Koga, Hiroshi, Hinotsu, Shiro, Shinohara, Nobuo, Oya, Mototsugu, Miki, Tsuneharu

“…Objective:  To characterize the clinical outcome in a large contemporary series of Japanese patients with newly diagnosed Ta, T1 non‐muscle invasive bladder…”
Get full text

External validation of a genitourinary cancer-specific prognostic scoring system to predict survival for patients with bone metastasis (modified B-FOM scoring model): Comparison with other scoring models in terms of accuracy by Owari, Takuya, Miyake, Makito, Nakai, Yasushi, Tanaka, Nobumichi, Itami, Yoshitaka, Hirao, Shuya, Momose, Hitoshi, Nakagawa, Yoshinori, Iida, Kouta, Maesaka, Fumisato, Shimizu, Takuto, Iemura, Yusuke, Matsumoto, Yoshihiro, Kuwada, Masaomi, Otani, Takeshi, Otsuka, Kenji, Okajima, Eijiro, Hosokawa, Yukinari, Okamura, Ryosuke, Fujimoto, Kiyohide

“…•Bone is one of major metastatic site in patients with genitourinary (GU) cancer.•Accurately predicting survival of patients with bone metastasis (BM) is…”
Get full text

Risk-stratified survival rates and predictors of biochemical recurrence after radical prostatectomy in a Nara, Japan, cohort study by Tanaka, Nobumichi, Fujimoto, Kiyohide, Hirayama, Akihide, Torimoto, Kazumasa, Okajima, Eijiro, Tanaka, Masahiro, Miyake, Makito, Shimada, Keiji, Konishi, Noboru, Hirao, Yoshihiko

“…Background The aim of this study was to evaluate the oncological outcomes in patients who underwent radical prostatectomy in various risk groups. Methods The…”
Get full text

Site-specific Response to Nivolumab in Renal Cell Carcinoma by NEGISHI, TAKAHITO, FURUBAYASHI, NOBUKI, NAKAGAWA, TOHRU, NISHIYAMA, NAOTAKA, KITAMURA, HIROSHI, HORI, YOSHIFUMI, KUROIWA, KENTAROU, SON, YUHYON, SEKI, NARIHITO, TOMODA, TOSHIHISA, OKAJIMA, EIJIRO, NAKAMURA, MOTONOBU

Get full text

Prognostic factors of renal cell carcinoma with extension into inferior vena cava by Tanaka, Masahiro, Fujimoto, Kiyohide, Okajima, Eijiro, Tanaka, Nobumichi, Yoshida, Katsunori, Hirao, Yoshihiko

“…Objective:  To evaluate the prognosis of our series of patients with renal cell carcinoma (RCC) and tumor thrombus involving inferior vena cava (IVC) treated…”
Get full text

Bladder cancer develops 6 years earlier in current smokers: Analysis of bladder cancer registry data collected by the cancer registration committee of the Japanese Urological Association by Hinotsu, Shiro, Akaza, Hideyuki, Miki, Tsuneharu, Fujimoto, Hiroyuki, Shinohara, Nobuo, Kikuchi, Eiji, Mizutani, Yoichi, Koga, Hirofumi, Okajima, Eijiro, Okuyama, Akihiko

“…Objectives:  It is generally recognized that cigarette smoking is the most important risk factor for bladder cancer. The present study was undertaken to…”
Get full text

Cancer death from non-muscle invasive bladder cancer: Report of the Japanese Urological Association of data from the 1999-2001 registry in Japan by Okajima, Eijiro, Fujimoto, Hiroyuki, Mizutani, Yoichi, Kikuchi, Eiji, Koga, Hirofumi, Hinotsu, Shiro, Shinohara, Nobuo, Miki, Tsuneharu

“…Objectives:  Our aim was to clarify the risk factors of cancer death in order to reduce mortality from T1 bladder cancer. Methods:  The Japan registration…”
Get full text

Weekly Paclitaxel and Carboplatin against Advanced Transitional Cell Cancer after Failure of a Platinum-Based Regimen by Kouno, Tsutomu, Ando, Masashi, Yonemori, Kan, Matsumoto, Koji, Shimizu, Chikako, Katsumata, Noriyuki, Komiyama, Motokiyo, Okajima, Eijiro, Matsuoka, Naoki, Fujimoto, Hiroyuki, Fujiwara, Yasuhiro

“…Abstract Objective Weekly administration of paclitaxel plus carboplatin is hypothesized to be an effective second-line treatment for advanced transitional cell…”
Get full text

Improvement of the surgical curability of locally confined prostate cancer including non-organ-confined high-risk disease through retropubic radical prostatectomy with intentional wide resection by Okajima, Eijiro, Yoshikawa, Motokiyo, Masuda, Yasumasa, Shimizu, Kazuhiro, Tanaka, Nobumichi, Hirayama, Akihide, Shimada, Keiji, Fujimoto, Kiyohide, Hirao, Yoshihiko

“…Retropubic radical prostatectomy with intentional wide resection (RRP-WR), which enables clear location of the prostate apex and the performance of…”
Get full text

Survival of Metastatic Germ Cell Cancer Patients Assessed by International Germ Cell Consensus Classification in Japan by Shintaku, Ichiro, Satoh, Makoto, Okajima, Eijiro, Fujimoto, Hiroyuki, Kamoto, Toshiyuki, Ogawa, Osamu, Kawai, Koji, Akaza, Hideyuki, Tsukamoto, Taiji, Naito, Seiji, Miki, Tsuneharu, Arai, Yoichi

“…Background As a risk classification system of metastatic germ cell tumors, the International Germ Cell Consensus (IGCC) classification was proposed in 1997 and…”
Get full text

5-Fluorouracil incorporated into the tissue RNA of human and rat bladder carcinoma after administration of 1-(2-tetrahydrofuryl)-5-fluorouracil combined with uracil by Tsujimoto, Shigehiro, Fujimoto, Kiyohide, Okajima, Eijiro, Ozono, Seiichiro, Okajima, Eigoro, Hirao, Yoshihiko

“…Background UFT is an anticancer agent consisting of 1-(2-tetrahydrofuryl)-5-fluorouracil (5-FU) combined with uracil in a molar ratio of 1: 4. Its mechanisms…”
Get full text

Different Regulation of Vascular Endothelial Growth Factor Expression by the ERK and p38 Kinase Pathways in v-ras, v-raf, and v-myc Transformed Cells by Okajima, Eijiro, Thorgeirsson, Unnur P.

“…Here we show that vascular endothelial growth factor (VEGF) mRNA expression is up-regulated in oncogene transformed rat liver epithelial (RLE) cell lines and…”
Get full text

Inhibitory Effect of Tomato Juice on Rat Urinary Bladder Carcinogenesis after N‐Butyl‐N‐(4‐hydroxybutyl)nitrosamine Initiation by Okajima, Eijiro, Tsutsumi, Masahiro, Ozono, Seiichiro, Akai, Hiroyuki, Denda, Ayumi, Nishino, Hoyoku, Oshima, Syunji, Sakamoto, Hideki, Konishi, Yoichi

“…The effects of tomato juice on urinary bladder carcinogenesis were studied in male Fischer 344 rats initiated with N‐butyl‐N‐(4‐hydroxybutyl)nitrosamine (BBN)…”
Get full text

A Potential Role for Vascular Endothelial Growth Factor-D as an Autocrine Growth Factor for Human Breast Carcinoma Cells by AKAHANE, Manabu, AKAHANE, Takemi, SHAH, Amy, OKAJIMA, Eijiro, THORGEIRSSON, Unnur P

“…Background. Vascular endothelial growth factor-D (VEGF-D) binds and activates vascular endothelial growth factor receptor-2 (VEGFR-2), which signals for…”
Get full text